Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities
- PMID: 24573657
- DOI: 10.1007/s00259-014-2726-6
Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities
Abstract
Purpose: Knowledge of the presence and extent of bone infiltration is crucial for planning the resection of potential bone-infiltrating squamous cell carcinomas of the head and neck (HNSCC). Routinely, plain-film radiography, multislice computed tomography (MSCT) and magnetic resonance imaging (MRI) are used for preoperative staging, but they show relatively high rates of false-positive and false-negative findings. Scintigraphy with (99m)Tc-bisphosphonate has the ability to show increased metabolic bone activity. If combined with anatomical imaging (e.g. (SPECT)/CT), it facilitates the precise localization of malignant bone lesions. The aim of this study was to analyse the indications and advantages of SPECT/CT compared with standard imaging modalities and histology with regard to specificity and sensitivity
Methods: A longitudinally evaluated group of 30 patients with biopsy-proven HNSCC adjacent to the mandible underwent (99m)Tc-bisphosphonate SPECT/CT, MRI, MSCT and conventional radiography before partial or rim resection of the mandible was performed. Bone infiltration was first evaluated with plain films, MSCT and MRI. In a second reading, SPECT/CT data were taken into account. The results (region and certainty of bone invasion) were evaluated among the different imaging modalities and finally compared with histological specimens from surgical resection as the standard of reference. For a better evaluation of the hybrid property of SPECT/CT, a retrospectively evaluated group of 20 additional patients with tumour locations similar to those of the longitudinally examined SPECT/CT group underwent SPECT, MSCT and MRI. To assess the influence of dental foci on the specificity of the imaging modalities, all patients were separated into two subgroups depending on the presence or absence of teeth in the area of potential tumour-bone contact.
Results: Histologically proven bone infiltration was found in 17 patients (57 %) when analysed by conventional imaging modalities. SPECT/CT data revealed bone infiltration in two additional patients (7 %), who both showed discrete cortical bone erosion not visible by MSCT or MRI. There were no false-positive or false-negative findings on SPECT/CT. The quality criteria for detecting bone involvement in HNSCC by SPECT/CT were as follows: sensitivity 100 % (lower 95 % confidence interval limit 80 %), specificity 100 % (75 %), positive predictive value 100 % (80 %) and negative predictive value 100 % (75 %). Corresponding data for MRI were 95 % (76 %), 94 % (73 %), 95 % (76 %) and 94 % (73 %), and for MSCT were 89 % (71 %), 100 % (85 %), 100 % (86 %) and 88 % (69 %). In the retrospective evaluation SPECT showed results similar to SPECT/CT.
Conclusion: Hybrid SPECT/CT has a high specificity as it can provide additional information about the existence and local extent of malignant bone infiltration of the mandible. Although the sensitivity of conventional SPECT is similar to that of SPECT/CT, the latter provides a much better delineation of the local tumour-bone contact area. Based on this information, surgical intervention of the rim versus partial resection can be planned and performed more precisely. Patient outcome can be improved by avoiding undertreatment and unnecessary or overextended bone resections.
Similar articles
-
Defining secure surgical bone margins in head and neck squamous cell carcinomas: The diagnostic impact of intraoperative cytological assessment of bone resection margins compared with preoperative imaging.Oral Oncol. 2020 Mar;102:104579. doi: 10.1016/j.oraloncology.2020.104579. Epub 2020 Feb 12. Oral Oncol. 2020. PMID: 32062159
-
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):92-102. doi: 10.1007/s00259-015-3145-z. Epub 2015 Aug 6. Eur J Nucl Med Mol Imaging. 2016. PMID: 26243264
-
Integrated multislice CT and Tc-99m Sestamibi SPECT-CT evaluation of solitary pulmonary nodules.Radiol Med. 2006 Mar;111(2):213-24. doi: 10.1007/s11547-006-0022-7. Radiol Med. 2006. PMID: 16671379 English, Italian.
-
Imaging in head and neck oncology.Surg Oncol Clin N Am. 2004 Jan;13(1):13-35. doi: 10.1016/S1055-3207(03)00124-8. Surg Oncol Clin N Am. 2004. PMID: 15062359 Review.
-
Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.Nucl Med Commun. 2014 Feb;35(2):123-34. doi: 10.1097/MNM.0000000000000022. Nucl Med Commun. 2014. PMID: 24220055 Review.
Cited by
-
Determination of adequate bony resection margins in inflammatory jaw pathologies using SPECT-CT in primary mandibular reconstruction with virtually planned vascularized bone flaps.Clin Oral Investig. 2025 Jan 28;29(1):93. doi: 10.1007/s00784-025-06170-2. Clin Oral Investig. 2025. PMID: 39870950 Free PMC article.
-
[On the relevance of histopathology results in oropharyngeal cancer with mandibular involvement and the necessary imaging].HNO. 2025 Jan;73(1):60-66. doi: 10.1007/s00106-024-01519-7. Epub 2024 Oct 25. HNO. 2025. PMID: 39455446 German.
-
A Review on the Usage of Bone Single-Photon Emission Computed Tomography/Computed Tomography in Detecting Skeletal Metastases in the Post-COVID-19 Era: Is it Time to Ditch Planar and Single-Photon Emission Computed Tomography only Gamma Camera Systems?Indian J Nucl Med. 2023 Apr-Jun;38(2):191-200. doi: 10.4103/ijnm.ijnm_142_22. Epub 2023 Jun 8. Indian J Nucl Med. 2023. PMID: 37456181 Free PMC article. Review.
-
Cutaneous squamous cell carcinoma of the scalp in the immunocompromised patient: review of 53 cases.Oral Maxillofac Surg. 2016 Jun;20(2):171-5. doi: 10.1007/s10006-016-0545-6. Epub 2016 Jan 16. Oral Maxillofac Surg. 2016. PMID: 26780196 Review.
-
Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study.J Oral Maxillofac Surg. 2020 Oct;78(10):1736-1747. doi: 10.1016/j.joms.2020.05.022. Epub 2020 May 19. J Oral Maxillofac Surg. 2020. PMID: 32554066 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical